KL50 THERAPEUTICS, LLC

Westport, CT · Biotech · Private

Small-molecule DNA alkylating agents that generate MGMT-dependent, MMR-independent lesions to treat MGMT-silenced cancers

Grants
$1.1M
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Development of Targeted Damaging Agents for the Treatment of Drug-Resistant Gliomas$1,107,901
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3098ImmPORT Therapeutics Inc dba Antigen Discovery Inc——
3099ASSUAGE PHARMACEUTICALS, INC.——
3100TUNITAS THERAPEUTICS, INC.——
3101KL50 THERAPEUTICS, LLC——
3102Medical Guidance Systems LLC——
3103TRIANGLE THERAPEUTICS INC.——
3104Thimble Therapeutics Inc——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.